MindWalk Holdings (HYFT) Common Equity (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly Common Equity came in at $8.6 million in Q2 2026, down 48.38% year-over-year from $16.6 million in Q2 2025, and down 19.95% quarter-over-quarter from $10.7 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) Common Equity (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Common Equity for 7 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Common Equity fell 48.38% year-over-year to $8.6 million in Q2 2026; TTM through Apr 2026 was $8.6 million, a 48.38% decrease from a year earlier, with the FY2026 full-year figure at $8.5 million, down 49.8% from the prior year.
- Common Equity was $8.6 million for Q2 2026 at MindWalk Holdings, down from $10.7 million in the prior quarter.
- Over five years, Common Equity peaked at $59.4 million in Q2 2022 and troughed at $8.6 million in Q2 2026.
- A 5-year average of $30.9 million and a median of $32.0 million in 2022 frame the typical range for Common Equity.
- Across the five-year window, Common Equity soared 50.26% in 2022 and sank 53.52% in 2025, its largest moves.
- Over 5 years, Common Equity stood at $46.5 million in 2022, then slipped by 15.76% to $39.2 million in 2023, then plunged by 40.36% to $23.4 million in 2024, then plunged by 45.35% to $12.8 million in 2025, then sank by 32.85% to $8.6 million in 2026.
- The last three Common Equity figures came in at $8.6 million (Q2 2026), $10.7 million (Q1 2026), and $12.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.83 Bn | 40.75 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 16.52 Bn | 16.02 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Charles River Laboratories International | 13.15 Bn | 12.95 Bn | 452.07 Mn | 2.85 Bn |
| 4 | Icon | 12.73 Bn | 11.81 Bn | 479.29 Mn | 9.38 Bn |
| 5 | Fortrea Holdings | 1.60 Bn | 1.43 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Evotec SE | 626.85 Mn | 200.98 Mn | - | 773.64 Mn |
| 7 | Ginkgo Bioworks Holdings | 419.76 Mn | 335.22 Mn | 18.44 Mn | 420.28 Mn |
| 8 | Champions Oncology | 70.27 Mn | 70.27 Mn | 7.03 Mn | 4.07 Mn |
| 9 | MindWalk Holdings | 59.37 Mn | 51.09 Mn | 1.82 Mn | 8.57 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 8.57 Mn |
| Jan 31, 2026 | 10.71 Mn |
| Oct 31, 2025 | 12.76 Mn |
| Jul 31, 2025 | 15.10 Mn |
| Apr 30, 2025 | 16.60 Mn |
| Jan 31, 2025 | 17.58 Mn |
| Oct 31, 2024 | 23.35 Mn |
| Jul 31, 2024 | 23.98 Mn |
| Apr 30, 2024 | 26.31 Mn |
| Jan 31, 2024 | 37.82 Mn |
| Oct 31, 2023 | 39.16 Mn |
| Jul 31, 2023 | 41.02 Mn |
| Apr 30, 2023 | 43.24 Mn |
| Jan 31, 2023 | 45.29 Mn |
| Oct 31, 2022 | 46.49 Mn |
| Jul 31, 2022 | 51.50 Mn |
| Apr 30, 2022 | 59.44 Mn |
| Jan 31, 2022 | 37.68 Mn |
| Oct 31, 2021 | 40.49 Mn |
| Jul 31, 2021 | 45.13 Mn |